Annals of Clinical Neurophysiology

The Korean Society of Clinical Neurophysiology (대한임상신경생리학회)
권호 표지
DOI QR코드

DOI QR Code

Caveolinopathy pesenting with excercise induced stiffness and transient muscle mounding

  • Song-Hwa Chae (Department of Neurology, Pusan National University Yangsan Hospital) ;
  • Jin-Hong Shin (Department of Neurology, Pusan National University Yangsan Hospital) ;
  • Dae-Seong Kim (Department of Neurology, Pusan National University Yangsan Hospital)
  • Received : 2024.01.31
  • Accepted : 2024.02.27
  • Published : 2024.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Rippling muscle disease (RMD) is caused by dominant mutations of the caveolin-3 gene (CAV3), and presents with overlapping limb-girdle muscle weakness, elevated creatine kinase (hyper-CKemia), RMD, and distal myopathy. We report a patient with a CAV3 mutation who presented with myalgia, exercise-induced muscle stiffness, hyperCKemia, and percussion-induced rapid muscle contraction and muscle mounding. A familial genetic study revealed the same mutation in two family members, with physical examinations showing that both of them had rippling muscles.

Keywords

Acknowledgement

This work was supported by a 2-year Research Grant of Pusan National University.

References

  1. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 2004;62:538-543. https://doi.org/10.1212/WNL.62.4.538
  2. Burns RJ, Bretag AH, Blumbergs PC, Harbord MG. Benign familial disease with muscle mounding and rippling. J Neurol Neurosurg Psychiatry 1994;57:344-347. https://doi.org/10.1136/jnnp.57.3.344
  3. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998;18:365-368. https://doi.org/10.1038/ng0498-365
  4. Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The human gene mutation database (HGMD®: optimizing its use in a clinical diagnostic or research setting. Hum Genet 2020;139:1197-1207. https://doi.org/10.1007/s00439-020-02199-3
  5. Straub V, Murphy A, Udd B, Corrado A, Ayme S, Bonneman C, et al. 229th ENMC international workshop: limb girdle muscular dystrophies-nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord 2018; 28:702-710. https://doi.org/10.1016/j.nmd.2018.05.007
  6. Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: from the biology of caveolin-3 to human diseases. Eur J Hum Genet 2010;18:137-145. https://doi.org/10.1038/ejhg.2009.103
  7. Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, et al. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation 2008;118:1979-1988. https://doi.org/10.1161/CIRCULATIONAHA.108.788331
  8. Nixon SJ, Wegner J, Ferguson C, Mery PF, Hancock JF, Currie PD, et al. Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning. Hum Mol Genet 2005;14:1727-1743. https://doi.org/10.1093/hmg/ddi179
  9. Berling E, Verebi C, Venturelli N, Vassilopoulos S, Behin A, Tard C, et al. Caveolinopathy: clinical, histological, and muscle imaging features and follow-up in a multicenter retrospective cohort. Eur J Neurol 2023;30:2506-2517. https://doi.org/10.1111/ene.15832
  10. Maki T, Matsumoto R, Kohara N, Kondo T, Son I, Mezaki T, et al. Rippling is not always electrically silent in rippling muscle disease. Muscle Nerve 2011;43:601-605. https://doi.org/10.1002/mus.21947